Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Plasma cotinine indicates an increased risk of preeclampsia in previous and passive smokers.

Luo ZC, Julien P, Wei SQ, Audibert F, Smith GN, Fraser WD; MIROS study group.

Am J Obstet Gynecol. 2014 Mar;210(3):232.e1-5. doi: 10.1016/j.ajog.2013.09.041. Epub 2013 Oct 2.

PMID:
24096183
2.

Self-reported tobacco smoke exposure and plasma cotinine levels during pregnancy--a validation study in Northern Japan.

Sasaki S, Braimoh TS, Yila TA, Yoshioka E, Kishi R.

Sci Total Environ. 2011 Dec 15;412-413:114-8. doi: 10.1016/j.scitotenv.2011.10.019. Epub 2011 Nov 10.

PMID:
22078365
3.

Environmental tobacco smoke exposure among pregnant women: impact on fetal biometry at 20-24 weeks of gestation and newborn child's birth weight.

Hanke W, Sobala W, Kalinka J.

Int Arch Occup Environ Health. 2004 Jan;77(1):47-52. Epub 2003 Oct 31.

PMID:
14593481
4.

Association of self-reported passive smoking in pregnant women with cotinine level of maternal urine and umbilical cord blood at delivery.

Baheiraei A, Banihosseini SZ, Heshmat R, Mota A, Mohsenifar A.

Paediatr Perinat Epidemiol. 2012 Jan;26(1):70-6. doi: 10.1111/j.1365-3016.2011.01242.x. Epub 2011 Nov 3.

PMID:
22150710
6.

Reduction of tobacco smoke exposure for pregnant passive smokers using feedback of urinary cotinine test results.

Higashida Y, Ohashi K.

J Obstet Gynaecol Res. 2014 Apr;40(4):1015-22. doi: 10.1111/jog.12285. Epub 2014 Jan 15.

PMID:
24428542
7.

Maternal active and passive smoking and hypertensive disorders of pregnancy: risk with trimester-specific exposures.

Engel SM, Scher E, Wallenstein S, Savitz DA, Alsaker ER, Trogstad L, Magnus P.

Epidemiology. 2013 May;24(3):379-86. doi: 10.1097/EDE.0b013e3182873a73.

8.

Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study.

Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H, Dunning A, Garte S, Gormally E, Hainaut P, Malaveille C, Matullo G, Peluso M, Overvad K, Tjonneland A, Clavel-Chapelon F, Boeing H, Krogh V, Palli D, Panico S, Tumino R, Bueno-De-Mesquita B, Peeters P, Berglund G, Hallmans G, Saracci R, Riboli E.

BMJ. 2005 Feb 5;330(7486):277. Epub 2005 Jan 28.

9.

Maternal tobacco exposure and cotinine levels in fetal fluids in the first half of pregnancy.

Jauniaux E, Gulbis B, Acharya G, Thiry P, Rodeck C.

Obstet Gynecol. 1999 Jan;93(1):25-9.

PMID:
9916950
10.

Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy.

George L, Granath F, Johansson AL, Cnattingius S.

Acta Obstet Gynecol Scand. 2006;85(11):1331-7.

PMID:
17091413
11.

Effect of passive smoking using maternal and neonatal salivary cotinine measurements.

Sachiyo K, Kumiko A, Keiko N, Kaori K, Sonomi O.

Nurs Res. 2012 Mar-Apr;61(2):140-4. doi: 10.1097/NNR.0b013e3182456690.

PMID:
22282157
12.

Reference values for hair cotinine as a biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: systematic review and meta-analysis.

Florescu A, Ferrence R, Einarson TR, Selby P, Kramer M, Woodruff S, Grossman L, Rankin A, Jacqz-Aigrain E, Koren G.

Ther Drug Monit. 2007 Aug;29(4):437-46. Review.

PMID:
17667798
13.

Maternal cotinine level during pregnancy and birthweight for gestational age.

Peacock JL, Cook DG, Carey IM, Jarvis MJ, Bryant AE, Anderson HR, Bland JM.

Int J Epidemiol. 1998 Aug;27(4):647-56.

PMID:
9758120
14.

Environmental tobacco smoke and risk of spontaneous abortion.

George L, Granath F, Johansson AL, Annerén G, Cnattingius S.

Epidemiology. 2006 Sep;17(5):500-5.

PMID:
16837826
15.

Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women.

Lindqvist R, Lendahls L, Tollbom O, Aberg H, Håkansson A.

Acta Obstet Gynecol Scand. 2002 Mar;81(3):240-4.

PMID:
11966481
16.

Fetal exposure to tobacco smoke products: a comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum.

Nafstad P, Kongerud J, Botten G, Urdal P, Silsand T, Pedersen BS, Jaakkola JJ.

Acta Obstet Gynecol Scand. 1996 Nov;75(10):902-7.

PMID:
9003090
17.

Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study.

Tunstall-Pedoe H, Brown CA, Woodward M, Tavendale R.

J Epidemiol Community Health. 1995 Apr;49(2):139-43.

18.

Passive and active maternal smoking as measured by serum cotinine: the effect on birthweight.

Eskenazi B, Prehn AW, Christianson RE.

Am J Public Health. 1995 Mar;85(3):395-8.

19.

Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy.

Pichini S, Basagaña XB, Pacifici R, Garcia O, Puig C, Vall O, Harris J, Zuccaro P, Segura J, Sunyer J.

Environ Health Perspect. 2000 Nov;108(11):1079-83.

20.

[Effects of active and passive smoking during pregnancy on the development of gestational hypertension and fetal hypotrophy].

Krzyścin M, Dera-Szymanowska A, Napierała M, Chuchracki M, Markwitz W, Breborowicz GH, Florek E.

Przegl Lek. 2015;72(3):131-5. Polish.

PMID:
26731869

Supplemental Content

Support Center